160 related articles for article (PubMed ID: 21790212)
21. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.
Chen L; Zhang W; Yan W; Han L; Zhang K; Shi Z; Zhang J; Wang Y; Li Y; Yu S; Pu P; Jiang C; Jiang T; Kang C
Carcinogenesis; 2012 Nov; 33(11):2276-82. PubMed ID: 22871495
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project.
Yang M; Bai HX; Yang L
J Neurooncol; 2017 Aug; 134(1):241-242. PubMed ID: 28547591
[No Abstract] [Full Text] [Related]
23. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
24. Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1.
Que T; Song Y; Liu Z; Zheng S; Long H; Li Z; Liu Y; Wang G; Liu Y; Zhou J; Zhang X; Fang W; Qi S
Oncogene; 2015 Sep; 34(38):4952-63. PubMed ID: 25597410
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
[TBL] [Abstract][Full Text] [Related]
26. Genetic analysis to complement histopathological diagnosis of brain tumors.
Nakamura M; Shimada K; Ishida E; Nakase H; Konishi N
Histol Histopathol; 2007 Mar; 22(3):327-35. PubMed ID: 17163407
[TBL] [Abstract][Full Text] [Related]
27. Emerging roles of microRNA in modulating cell-death processes in malignant glioma.
Palumbo S; Miracco C; Pirtoli L; Comincini S
J Cell Physiol; 2014 Mar; 229(3):277-86. PubMed ID: 23929496
[TBL] [Abstract][Full Text] [Related]
28. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
29. miRNA Multiplayers in glioma. From bench to bedside.
Rolle K
Acta Biochim Pol; 2015; 62(3):353-65. PubMed ID: 26307768
[TBL] [Abstract][Full Text] [Related]
30. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
31. [Molecular genetic analysis for malignant gliomas: clinical implications and future directions].
Mizoguchi M; Shono T
No Shinkei Geka; 2008 Jan; 36(1):83-91. PubMed ID: 18232326
[No Abstract] [Full Text] [Related]
32. An introduction to molecular analysis and characterization of gliomas.
Ausman JI
Surg Neurol; 2005 Oct; 64(4):285. PubMed ID: 16181992
[No Abstract] [Full Text] [Related]
33. Circulating MicroRNAs as Potential Biomarkers in Glioma: A Mini-Review.
Choppavarapu L; Kandi SM
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):195-202. PubMed ID: 32744979
[TBL] [Abstract][Full Text] [Related]
34. Diffuse Midline Gliomas without the H3 K27M Mutation: Surgical Biopsy is Needed to Better our Diagnostic Understanding.
Lu VM; Raghunathan A; Schwartz JD; Daniels DJ
World Neurosurg; 2020 May; 137():472-473. PubMed ID: 32365434
[No Abstract] [Full Text] [Related]
35. Prioritizing uncharacterized genes in the search for glioma biomarkers.
Towner RA; Wren JD
CNS Oncol; 2014 Mar; 3(2):93-5. PubMed ID: 25055012
[No Abstract] [Full Text] [Related]
36. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers usher in era of personalized care for malignant glioma patients.
Chakravarti A; Palanichamy K; Bell EH
CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291
[No Abstract] [Full Text] [Related]
38. [Biomarkers of glioma: recent advance and potential applications].
Yu SZ; Wang Q
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):145-7. PubMed ID: 19575846
[No Abstract] [Full Text] [Related]
39. Proteomics of gliomas: initial biomarker discovery and evolution of technology.
Kalinina J; Peng J; Ritchie JC; Van Meir EG
Neuro Oncol; 2011 Sep; 13(9):926-42. PubMed ID: 21852429
[TBL] [Abstract][Full Text] [Related]
40. EGFR targeted fluorescence imaging in gliomas.
Poptani H
Acad Radiol; 2010 Jan; 17(1):1-2. PubMed ID: 19969252
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
